Lian, B., Chen, Y., Wang, H., Zhang, W., Zhang, X., Fang, M., Sun, Y., Wu, D., Cui, J., Liang, X., Li, K., Feng, H., Chu, Q., Pu, X., Pan, Y., Sun, M., Zhou, M., Chen, Y., Wang, H., Guo, J. (2025). Efficacy and safety results of a first-in-class PD-1/IL-2
            <sup>α-bias</sup>
            bispecific antibody fusion protein IBI363 in patients (pts) with immunotherapy-treated, advanced acral and mucosal melanoma.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.2502